BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moura RA, Fonseca JE. JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis. Front Med (Lausanne) 2020;7:607725. [PMID: 33614673 DOI: 10.3389/fmed.2020.607725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Schäfer A, Kovacs MS, Eder A, Nigg A, Feuchtenberger M. Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis. Clin Rheumatol 2022. [PMID: 35965290 DOI: 10.1007/s10067-022-06329-2] [Reference Citation Analysis]
2 Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol 2022;13:945129. [DOI: 10.3389/fimmu.2022.945129] [Reference Citation Analysis]
3 Plantone D, Pardini M, Locci S, Nobili F, De Stefano N. B Lymphocytes in Alzheimer's Disease-A Comprehensive Review. J Alzheimers Dis 2022. [PMID: 35754274 DOI: 10.3233/JAD-220261] [Reference Citation Analysis]
4 Wang F, Liu G, Xiang L, Yuan J, Tao Y, Zhang L, Zhang A, Chang X. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors. J Clin Lab Anal 2022;:e24449. [PMID: 35500150 DOI: 10.1002/jcla.24449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tawfeek GA, Eseily HA. A novel function of collagen/PCL nanofiber interaction with MSCs in osteoarthritis is potentiation its immunomodulatory effect through increased ICAM expression. Transplant Immunology 2022. [DOI: 10.1016/j.trim.2022.101625] [Reference Citation Analysis]
6 Markovics A, Rosenthal KS, Mikecz K, Carambula RE, Ciemielewski JC, Zimmerman DH. Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models. Biomedicines 2022;10:44. [DOI: 10.3390/biomedicines10010044] [Reference Citation Analysis]
7 Wang C, Lin J, Wang Y, Hsi DH, Chen J, Liu T, Zhou Y, Ren Z, Zeng Z, Cheng L, Ge J. Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment. Front Pharmacol 2021;12:770631. [PMID: 34938185 DOI: 10.3389/fphar.2021.770631] [Reference Citation Analysis]
8 Ahmed S, Jacob B, Carsons SE, De Leon J, Reiss AB. Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk. Pharmaceuticals (Basel) 2021;15:11. [PMID: 35056068 DOI: 10.3390/ph15010011] [Reference Citation Analysis]
9 Iancovici L, Khateeb D, Harel O, Peri R, Slobodin G, Hazan Y, Melamed D, Kessel A, Bar-On Y. Rheumatoid arthritis patients treated with Janus kinase inhibitors show reduced humoral immune responses following BNT162b2 vaccination. Rheumatology (Oxford) 2021:keab879. [PMID: 34849628 DOI: 10.1093/rheumatology/keab879] [Reference Citation Analysis]
10 Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R. The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J 2021:ehab447. [PMID: 34343257 DOI: 10.1093/eurheartj/ehab447] [Reference Citation Analysis]
11 Matsumoto T, Sato Y, Kobayashi T, Ito E, Soma T, Kimura A, Miyamoto K, Kobayashi S, Harato K, Matsumoto M, Nakamura M, Niki Y, Miyamoto T. Synoviolin is not a pathogenic factor for auto-inflammatory diseases. Biochem Biophys Res Commun 2021;558:183-8. [PMID: 33932778 DOI: 10.1016/j.bbrc.2021.04.093] [Reference Citation Analysis]